Ogden Christopher - Insider Non-Derivative Transactions at CytomX Therapeutics, Inc. (CTMX) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Aug 20, 2024, Ogden Christopher's relationship to CytomX Therapeutics, Inc. (CTMX) is Officer (Chief Financial Officer), and currently has 110,061 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other CTMX insiders.
Data Source: SEC.
Ogden Christopher - Insider Non-Derivative Transactions of CTMX Common Stock
Ogden Christopher - Insider Non-Derivative Transactions at CTMX
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Aug 21, 2024 | Sell -- (Common Stock) | 1984 | 1.23 | 108077 |
| Aug 21, 2024 | M -- (Common Stock) | 6875 | 0 | 110061 |
| Jun 13, 2024 | Acquisition -- (Common Stock) | 17500 | 0 | 103186 |
| Mar 20, 2024 | Sell -- (Common Stock) | 2971 | 2.09 | 85686 |
| Jan 19, 2024 | Acquisition -- (Common Stock) | 40000 | 0 | 88657 |
| Dec 21, 2023 | Sell -- (Common Stock) | 1990 | 1.38 | 48657 |
| Dec 18, 2023 | M -- (Common Stock) | 6875 | 0 | 50647 |
| Mar 17, 2023 | Sell -- (Common Stock) | 516 | 1.98 | 37772 |
| Feb 3, 2023 | Acquisition -- (Common Stock) | 25000 | 0 | 38288 |